Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ·Healthcare·Biotechnology
$30.89
—
Mkt Cap $559.55M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$40.00
Range $38.00 – $42.00
Implied Upside
+29.5%
Consensus $40.00 vs current $30.89
NASDAQ·Healthcare·Biotechnology
$30.89
—
Mkt Cap $559.55M
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$40.00
Range $38.00 – $42.00
+29.5%
Consensus $40.00 vs current $30.89